Neoadjuvant Tislelizumab Combined with Chemoradiotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm Phase II Study and Exploration of Immunologic Features

被引：0
|
作者：
Jin, P. [1 ]
Gao, Y. [1 ]
Fu, Z. [1 ]
Yang, W. [1 ]
Meng, X. [2 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[2] Shandong Canc Hosp & Inst, Jinan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3003
引用
收藏
页码：E454 / E454
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)
    van den Ende, Tom
    de Clercq, Nicolien C.
    Henegouwen, Mark I. van Berge
    Gisbertz, Suzanne S.
    Geijsen, E. D.
    Verhoeven, R. H. A.
    Meijer, Sybren L.
    Schokker, Sandor
    Dings, M. P. G.
    Bergman, Jacques J. G. H. M.
    Mohammad, Nadia Haj
    Ruurda, Jelle P.
    van Hillegersberg, Richard
    Mook, Stella
    Nieuwdorp, Max
    de Gruijl, Tanja D.
    Soeratram, Tanya T. D.
    Ylstra, Bauke
    van Grieken, Nicole C. T.
    Bijlsma, Maarten F.
    Hulshof, Maarten C. C. M.
    van Laarhoven, H. W. M.
    CLINICAL CANCER RESEARCH, 2021, 27 (12) : 3351 - 3359
  • [22] Tislelizumab plus chemotherapy as induction treatment followed by chemoradiotherapy or surgery in locally advanced hypopharyngeal squamous cell carcinoma: A single-arm, phase II trial
    Gui, Lin
    Liu, Shaoyan
    Wang, Xiaolei
    Zhang, Ye
    He, Xiaohui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Neoadjuvant tislelizumab combined with APF for patients with locally advanced head and neck squamous cell carcinoma: A prospective single-arm clinical trial
    Yan, Jing
    Wang, Kong-cheng
    Yang, Mi
    Gu, Ya-Jun
    Huang, Bin
    Zhu, Yahui
    Sha, Hui-zi
    Zhu, Jing
    Zhu, Chan
    Chen, Dong-sheng
    Qian, Xiao-Yun
    Shen, Xiao-hui
    Chen, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Neoadjuvant sintilimab plus chemotherapy for locally advanced resectable esophageal squamous cell carcinoma: a prospective, single-arm, phase II clinical trial (CY-NICE)
    Chen, Yuzhen
    Ren, Meiyu
    Li, Bin
    Meng, Yuqi
    Wang, Cheng
    Jiang, Peng
    Song, Tieniu
    Yang, Jianbao
    Zhu, Duojie
    Yu, Qiyao
    JOURNAL OF THORACIC DISEASE, 2023, 15 (12) : 6761 - 6775
  • [25] A single-arm, multicenter, phase II clinical study of tislelizumab plus albumin-bound paclitaxel/cisplatin as neoadjuvant therapy for borderline resectable esophageal squamous cell carcinoma
    Li, Xiaodong
    Xu, Congcong
    Qiu, Hongbin
    Chen, Dong
    Zhu, Kanghao
    Zhang, Bo
    Zhang, Jian
    Xu, Anyi
    Wang, Chunguo
    Shen, Jianfei
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (05)
  • [26] Neoadjuvant tislelizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis of a phase 2 study
    Zhuo, Na
    Qiu, Wei
    He, Jia
    Li, Li
    Wang, Qiang
    Yu, Shuangni
    Liu, Wei
    Zhao, Lin
    Bai, Chunmei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Neoadjuvant Chemoradiotherapy plus Sequential Tislelizumab Followed by Surgery for Esophageal Carcinoma (CRISEC study): A Prospective, Single-Arm, Phase II Trial
    Yang, J.
    Zhang, Z.
    Wu, B.
    Liu, C.
    Qin, Y.
    Wen, L.
    Wei, J.
    Xiao, G.
    Xing, S.
    Qu, Y.
    Huang, L.
    Wang, X.
    Wang, B.
    Zuo, Z.
    Can, F.
    Jiang, K.
    Yang, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E502 - E502
  • [28] Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial
    Yang, Jinsong
    Huang, Ai
    Yang, Kunyu
    Jiang, Ke
    BMC CANCER, 2023, 23 (01)
  • [29] Envafolimab plus chemotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II study
    Zhao, Jinbo
    Yan, Xiaolong
    Bai, Yuquan
    Duan, Hongtao
    Jiang, Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial
    Jinsong Yang
    Ai Huang
    Kunyu Yang
    Ke Jiang
    BMC Cancer, 23
12345